Phibro Animal Health Corporation ( PAHC) - Key Metrics
PAHC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $9.77 | $0.53 | $0.59 | $0.13 |
| 2026Q3 | $9.46 | $0.59 | $0.40 | $0.02 |
| 2026Q2 | $9.22 | $0.68 | $0.48 | $0.20 |
| 2026Q1 | $8.98 | $0.65 | $0.23 | -$0.11 |
| 2025Q4 | $9.35 | $0.43 | $0.53 | $0.20 |
PAHC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 22.42% | 14.54 |
| 2026Q3 | 20.26% | 23.44 |
| 2026Q2 | 17.71% | 13.74 |
| 2026Q1 | 18.34% | 15.56 |
| 2025Q4 | 28.24% | 15.20 |
PAHC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q4 | 0.41% | 0.38% |
| 2026Q3 | 0.04% | 0.22% |
| 2026Q2 | 0.55% | 0.32% |
| 2026Q1 | -0.27% | 0.30% |
| 2025Q4 | 0.79% | 0.47% |
PAHC
Price: $38.71
Dividend Yield: 1.29%
Forward Dividend Yield: 1.26%
Payout Ratio: 800.00%
Dividend Per Share: 0.48 USD
Earnings Per Share: 2.47 USD
P/E Ratio: 15.53
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 51500
Ebitda: 30.9 millionMarket Capitalization: 1.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 13
DGR10: 2.00%